"Today, the U.S. Food and Drug Administration approved Xuriden (uridine triacetate), the first FDA-approved treatment for patients with hereditary orotic aciduria. Hereditary orotic aciduria is a rare metabolic disorder, which has been reported in"...
- Advise patients to contact their physician immediately if
they experience unusual bruising or bleeding (e.g., nosebleeds, excessive bleeding
after brushing teeth, the appearance of blood in stools or urine, excessive
menstrual bleeding, petechiae, excessive bruising or persistent oozing from
superficial injuries) after hospital discharge.
- Such bruising or bleeding may occur for up to 1 week or longer following initial treatment.
- Advise patients to contact their physician immediately if they experience any signs and symptoms of delayed allergic reactions or serum sickness (e.g., rash, pruritus, urticaria) after hospital discharge.
Last reviewed on RxList: 4/17/2015
This monograph has been modified to include the generic and brand name in many instances.
Additional Crofab Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.